Auransa, Polaris harness AI, quantum computing to discover cancer drugs
The AI and QC specialists have joined to use AI and QC in order to discover biological pathways relevant to the treatment of triple-negative breast cancer.
Archives for August 16, 2022
Moderna’s next-gen COVID-19 booster becomes first authorized Omicron-specific bivalent vaccine
The first Omicron bivalent COVID-19 vaccine has been authorized: with the UK’s regulatory agency giving the green light to Moderna’s Spikevax Bivalent Original/Omicron booster shot.
Merck and Orna Therapeutics team up to advance next generation RNA tech
Merck and Orna Therapeutics have announced a collaboration agreement to discover, develop and commercialize Orna’s next generation oRNA technology across multiple programs, including vaccines and therapeutics in infectious disease and oncology.
Resilience and Mayo Clinic create biomanufacturing partnership for rare and complex conditions
Biomanufacturing company National Resilience has announced a strategic collaboration with Mayo Clinic in biomanufacturing to deliver novel biotherapeutics for rare and complex conditions.
Hired and retired: New appointments in the biopharma industry
Moderna, Curia and Abzena are among the companies welcoming new faces to top jobs.